Skip to content
MedsAcross

Medicine

Clindamycin Phoaphate Topical Solution USP, 1% 10 mg/mL topical solution

Clindamycin · Topical · Encube Ethicals
Available on requestPrescription onlyUS FDA

Clindamycin Phoaphate Topical Solution USP, 1% 10 mg/mL topical solution is a prescription medicine containing Clindamycin for topical use, marketed by Encube Ethicals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. Store at controlled room temperature 20° to 25°C (68°…

Key facts

Active ingredient (INN)
Clindamycin
Brand
Clindamycin Phoaphate Topical Solution USP, 1%
Strength
10 mg/mL
Dosage form
Topical solution
Route
Topical
Packs
1 bottle and 1 more
Marketing authorisation holder
Encube Ethicals
Manufacturers
Encube EthicalsNorthStar Rx
Origin register
US FDA, United States
Storage
Protect from freezing. Store at controlled room temperature 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D10AF01 Clindamycin
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
4 March 2019
Identifiers
RxCUI 309333DailyMed set ID 407f6d80-7de0-45d9-8ad2-5b95d233b96d, b2dfb76b-db09-43e7-8366-6791449a4918NDC 72603-321, 21922-002Application ANDA209914

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 bottle in 1 carton / 60 mL in 1 bottle21922-002-01Encube Ethicals4 March 2019
1 bottle in 1 carton / 30 mL in 1 bottle21922-002-21Encube Ethicals13 July 2020
1 bottle in 1 carton / 30 mL in 1 bottle72603-321-01Northstar Rx14 November 2024
1 bottle in 1 carton / 60 mL in 1 bottle72603-321-02Northstar Rx14 November 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 February 1970Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Clindamycin 10 mg/mL topical solution.

Compare all 3

Other strengths and forms of Clindamycin

Clinical summary

Clindamycin is a lincosamide antibacterial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. It is available as capsules, injection and gel for oral, topical and intravenous use. MedsAcross supplies Clindamycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Clindamycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Clindamycin Phoaphate Topical Solution USP, 1% 10 mg/mL topical solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.